Please or to access all these features

Feminism: Sex and gender discussions

The Dutch Leaks - Genspect - the Dutch Protocol

5 replies

CassOle · 16/11/2026 18:32

"The Origins of the Netherlands’ Most Infamous Export

Although gender-affirming care has become a medical scandal of global proportions, its modern form originated in the Netherlands. In the 1990s, Dutch clinicians developed what became known as the Dutch Protocol: the use of puberty blockers, cross-sex hormones and surgeries on gender-distressed young people. The practice of modifying the bodies of gender non-conforming children was rapidly adopted internationally and presented as the gold standard of evidence-based care. For all the wrong reasons, it has become one of the Netherlands’ most infamous exports."

Continues in the link: https://genspect.org/the-dutch-leaks-1/

OP posts:
ScrollingLeaves · 16/11/2026 20:05

Thank you very much. To think the Dutch Protocol which so many people copied has never been backed by evidence, or has ignored any advice and evidence research had suggested - one of the main suggestions being the need for widespread family involvement with the gender doctors first. ( Will the ‘conversion’ by children’s self ID pushers listen?)

The leaks are holes all over the dykes so to speak. And repairs are unlikely as it is the practitioners in good jobs who are in charge of judging themselves.

There were 11percent of deaths of MtF transitioners within 8 years.

Helleofabore · 16/11/2026 21:05

Thanks Cassole. I will download and read later this week.

CassOle · 16/11/2026 21:14

The effects of puberty blockers at 12, cross-sex hormones at 14, hysterectomy at 18, and phalloplasty at 19 are also covered in the interview that Buck Angel did recently.

OP posts:
Helleofabore · 16/11/2026 21:34

Remember this one

THE DUTCH PROTOCOL IS FALLING APART & OTHERS

The Dutch Protocol is falling apart By Stella O'Malley / 2 January 2023

First, Stella O’Malley writes about an article in Nederlands that is throwing a great deal of light on the Dutch Protocol. It also seems that there will be a review of the patients that the Dutch team had not previously included in their papers.

This article in the Nederlands points out the dangers on only using a nation’s own sources with no international input or even wide review.

genspect.org/the-dutch-model-is-falling-apart/

Then there was this documentary later in 2023
A documentary on the Dutch Protocol

"There are currently almost 3,000 young people on the waiting list for gender care in the Netherlands. They are vulnerable adolescents who are frequently subjected to discrimination. Many of them suffer severe mental distress. Doctors at the gender clinic in Amsterdam are pioneers in care for transgender young people. The treatment developed here years ago is now used worldwide. Now, criticism is growing. International experts are questioning the scientific evidence put forward by the clinicians in Amsterdam. Zembla investigates the Dutch transgender protocol.”

What this covers is that no gender clinic has been able to replicate the results of the Dutch paper. One patient of the group died due to the surgery complications of gender surgery and even de Vries questioned why no one seemed interested in that patient while accepting the study. Dr Riittakerttu Kaltiala (Professor of Pschyiatry, Tampere and who set up gender clinics) and Mikael Landen (Professor of Pscyhiatry, Gotenberg) and Dr Angela Samfjord (Head of Child and Adolescent Psychiatry at the University of Gotenberg ) all are interviewed about the quality of the study behind the protocol and its flaws that became apparent later. Ie. The 55 patients is so small and de Vries acknowledges that they are not really similar to todays cohort of adolescent transitioners. That only 32 filled in the survey with positive results. The others were not chased up and one died.

Gerard van Breukelen, a professor of Methodology at Maastricht university goes on record to say that the methodology of that initial study was weak. There was no control group so the conclusions should not have been considered as strong as the gender clinicians claimed. Other academics declined to be interviewed due to fear for their employment as it is such a contentious issue. When talking to de Vries, she mentions that many more studies have been done by other countries now. And the doco makers mention that all those studies de Vries refer to have stated that the evidence is low quality. A Swedish team led by Landen was asked to do a full review by the Swedish government and he confirms that the evidence was just not there. Hence the Swedish government withdrew treatment.

The mention the Cass review and discussion ‘locking in’ of identities contradicts the ‘time to think’ narrative. They interview three transitioners. One detransitionered before surgery and one is happy with transition but not with the process the team followed. The one who detransitioned was put on hormones despite not even socially transitioning as he felt wearing a dress was ‘a man wearing a dress’. But was put on hormones but didn’t go through surgery after all. It also wraps up with Lucy who was stuck on the waiting list and who believes that if she was given PBs, she would not have ended up transitioning. She has obviously detransitioned now after double mastectomy and testosterone, then ovaries and uterus removal.

Followed by the reanalysis

The peer reviewed reanalysis of the UK study. McPherson & Freedman both worked on the initial analysis of the patient clinical data.

https://www.tandfonline.com/doi/full/10.1080/0092623X.2023.2281986

Psychological Outcomes of 12–15-Year-Olds with Gender Dysphoria Receiving Pubertal Suppression in the UK: Assessing Reliable and Clinically Significant Change

Susan McPherson & David E. P. Freedman

Published online: 29 Nov 2023

Abstract
The evidence base for psychological benefits of GnRHA for adolescents with gender dysphoria (GD) was deemed “low quality” by the UK National Institute of Health and Care Excellence. Limitations identified include inattention to clinical importance of findings. This secondary analysis of UK clinical study data uses Reliable and Clinically Significant Change approaches to address this gap. The original uncontrolled study collected data within a specialist GD service. Participants were 44 12–15-year-olds with GD. Puberty was suppressed using “triptorelin”; participants were followed-up for 36 months. Secondary analysis used data from parent-report Child Behavior Checklists and Youth Self-Report forms. Reliable change results: 15–34% of participants reliably deteriorated depending on the subscale, time point and parent versus child report. Clinically significant change results: 27–58% were in the borderline (subclinical) or clinical range at baseline (depending on subscale and parent or child report). Rates of clinically significant change ranged from 0 to 35%, decreasing over time toward zero on both self-report and parent-report. The approach offers an established complementary method to analyze individual level change and to examine who might benefit or otherwise from treatment in a field where research designs have been challenged by lack of control groups and low sample sizes.

The Dutch Model is falling apart

Finally. the Dutch are speaking up. The country that recklessly decided that it was a good idea to offer experimental treatment to healthy young teens

https://genspect.org/the-dutch-model-is-falling-apart/

ScrollingLeaves · 16/11/2026 22:23

Thank you @Helleofabore I’ll read that later.

This is Dutch Leaks 1 from Genspec
https://genspect.org/wp-content/uploads/2026/11/Dutch-Leaks-Leak1-Nov-10-2026.pdf

https://genspect.org/wp-content/uploads/2026/11/Dutch-Leaks-Leak1-Nov-10-2026.pdf

New posts on this thread. Refresh page